Aug 14, 2024, 07:24
Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma
Christine Ryland shared on LinkedIn:
“I’m happy to share that I have started a new position as Director, Thought Leader Liaison for the multiple myeloma team at Kite Pharma!”
Source: Christine Ryland/LinkedIn
Christine Ryland is a seasoned pharmaceutical professional with expertise in sales, marketing, and KOL (Key Opinion Leader) strategic engagement. Currently serving as Director of Thought Leader Liaison at Kite Pharma, she previously held the role of KOL Strategic Engagement/Field Marketing Lead for Multiple Myeloma and Leukemia at Takeda Oncology.
Christine has a proven track record of leading cross-functional teams and effectively bridging commercial and medical objectives to drive success in the oncology field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 09:39
Nov 13, 2024, 08:59